News

Professor Tom Scriba has written an opinion piece for News24 in which he explains the safety profile of the 3 available COVID-19 vaccines & the benefits of receiving it.

Associate Professor Elisa Nemes has been appointed full member of the Institute of Infectious Disease and Molecular Medicine at the UCT Health Sciences Faculty.

The results from the ID93+GLA-SE TB vaccine clinical trial have just been published in the Lancet Respiratory Medicine journal. The candidate vaccine displayed an acceptable safety profile and provides encouraging evidence of vaccine-induced immune responses when given to cured TB patients at the end of treatment.

SATVI is seeking applications for a Project Manager who will manage clinical research projects within SATVI. NOW CLOSED